Sun Hong-li, Wang Hui, Chen Min-jun, Liu Ying-mei, Hu Zhi-dong, Liao Kang, Chu Yun-zhuo, Lei Jin-e, Zhang Bing, Yu Yun-song, Hu Bi-jie, Sun Zi-yong, Zhang Zheng, He Qi-yong
Department of Clinical Laboratory, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
Zhonghua Nei Ke Za Zhi. 2010 Sep;49(9):735-40.
To investigate antimicrobial resistance among gram-positive cocci in China in 2009.
From June to December 2009, 1169 consecutive and non-repetitive gram-positive cocci were collected from 12 teaching hospitals at 9 cities. The minimal inhibitory concentration (MIC) of antibacterial agents was determined by agar dilution method.
The prevalences of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant coagulase-negative Staphylococci (MRCoNS) were 45.3% (211/466) and 89.5% (214/239), respectively. The isolation rate of MRSA was 33.3% - 68.1% from different samples. All Staphylococci isolates were susceptible to vancomycin, teicoplanin and linezolid. Five point five percent (7/128) E.faecium strains were resistant to vancomycin. All E. faecalis strains were susceptible to vancomycin. About 99.1% (108/109) of E.faecalis and E.faecium were susceptible to linezolid. The prevalence of penicillin-intermediate Streptococcus pneumoniae (PISP) was 21.6% (48/222). Only 1 (0.5%, 1/222) Streptococcus pneumoniae strain was resistant to penicillin. Teicoplanin, vancomycin, linezolid and tigecycline were the most active agents against Streptococcus pneumoniae (susceptible rate 100%).
The high prevalence of methicillin-resistance is among Staphylococcus strains. Different samples show a different MRSA prevalence. Teicoplanin, vancomycin and linezolid show very high activity to Staphylococci, E. faecalis, E. faecium and Streptococcus pneumoniae.
调查2009年中国革兰氏阳性球菌的耐药情况。
2009年6月至12月,从9个城市的12家教学医院收集了1169株连续且不重复的革兰氏阳性球菌。采用琼脂稀释法测定抗菌药物的最低抑菌浓度(MIC)。
耐甲氧西林金黄色葡萄球菌(MRSA)和耐甲氧西林凝固酶阴性葡萄球菌(MRCoNS)的发生率分别为45.3%(211/466)和89.5%(214/239)。不同样本中MRSA的分离率为33.3% - 68.1%。所有葡萄球菌分离株对万古霉素、替考拉宁和利奈唑胺敏感。5.5%(7/128)的粪肠球菌菌株对万古霉素耐药。所有粪链球菌菌株对万古霉素敏感。约99.1%(108/109)的粪肠球菌和屎肠球菌对利奈唑胺敏感。青霉素中介肺炎链球菌(PISP)的发生率为21.6%(48/222)。仅1株(0.5%,1/222)肺炎链球菌菌株对青霉素耐药。替考拉宁、万古霉素、利奈唑胺和替加环素是对肺炎链球菌活性最强的药物(敏感率100%)。
葡萄球菌菌株中甲氧西林耐药的发生率较高。不同样本显示出不同的MRSA发生率。替考拉宁、万古霉素和利奈唑胺对葡萄球菌、粪肠球菌、屎肠球菌和肺炎链球菌显示出非常高的活性。